Invention Grant
- Patent Title: Co-crystals of neflamapimod (VX-745)
-
Application No.: US16648267Application Date: 2018-09-18
-
Publication No.: US11466008B2Publication Date: 2022-10-11
- Inventor: John Jahangir Alam , Jeffrey Douglas Wilson
- Applicant: EIP Pharma, LLC
- Applicant Address: US MA Boston
- Assignee: EIP Pharma, LLC
- Current Assignee: EIP Pharma, LLC
- Current Assignee Address: US MA Boston
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2018/051558 WO 20180918
- International Announcement: WO2019/056003 WO 20190321
- Main IPC: A61K31/5025
- IPC: A61K31/5025 ; C07D487/04 ; A61K47/12
Abstract:
Provided herein are co-crystal forms comprising 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one (VX-745): and compositions thereof, useful as inhibitors of one or more protein kinases and which exhibit desirable characteristics for the same.
Public/Granted literature
- US20200308176A1 CO-CRYSTALS OF NEFLAMAPIMOD (VX-745) Public/Granted day:2020-10-01
Information query
IPC分类:
